Sean Maduck - 19 Aug 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck
Issuer symbol
CORT
Transactions as of
19 Aug 2022
Net transactions value
+$22,394
Form type
4
Filing time
22 Aug 2022, 19:32:35 UTC
Previous filing
16 Aug 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $33,600 +15,000 +37% $2.24* 55,024 19 Aug 2022 Direct
transaction CORT Common Stock Tax liability $11,206 -406 -0.74% $27.60 54,618 19 Aug 2022 Direct F1
holding CORT Common Stock 10,000 19 Aug 2022 See Footnote F2
holding CORT Common Stock 10,000 19 Aug 2022 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 19 Aug 2022 Common Stock 15,000 $2.24 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price arising from a net (cashless) exercise of stock options that occurred on August 19, 2022. The options subject to the net exercise were to expire on November 1, 2022.
F2 Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F3 Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.
F4 Fully exercisable.

Remarks:

President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.